Cognitive impairment in AD is commonly tested through recognition memory in animal models, which have shown improvement after treatment with the S1R agonists DMT, AF710B, pridopidine, OZP002, LS-1-137, and WLB-87848. This evidence concerns the gene TMBIM4 and Alzheimer disease.